Pharmaceutical Compounding
2 articles on Pharmaceutical Compounding, researched and written by the Shotlee Editorial Team from primary sources.
Healthcare Policy & Regulation
FDA Committee Supports Peptide Compounding: What's Next for Compounders and Telehealth?
The FDA's Pharmacy Compounding Advisory Committee has voted to recommend adding several peptides to the 503A Bulks List. This decision could significantly impact how compounded peptide products are accessed and utilized. Discover the potential next steps and what it means for healthcare providers and businesses.
10 min read
Peptide Therapy
Peptide Gold Rush: Deregulation Set to Supercharge Shadow Industry
Peptides, once a Silicon Valley biohacking secret, are exploding in popularity—search interest now tops Ozempic. With RFK Jr. poised to reverse FDA restrictions, compounding pharmacies and telehealth platforms are racing to supply them legally. This could propel the $52B peptide market to $87B by 2035.
5 min read